| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Squarer Ron serves as a Director at ADCT and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $380K at current prices.
The biggest single holding is ADCT (~$380K) as Director. The recent filings there lean toward selling, a net 6,995 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | ADCT Adc Therapeutics SA | Director | Sell | 6,995 | $2.89 | $20,215.55 | -8.0% | +9.2% | +15.6% |